306 related articles for article (PubMed ID: 1804896)
1. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
2. [How should leprosy be treated?].
Mahé A
Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
[No Abstract] [Full Text] [Related]
3. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
[No Abstract] [Full Text] [Related]
4. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Young RJ; Gilson RT; Elston DM
Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
[TBL] [Abstract][Full Text] [Related]
5. Dapsone syndrome: an incomplete form.
Jaswal R; Thami GP; Kanwar AJ
Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
[No Abstract] [Full Text] [Related]
6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
7. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
8. Multi-drug therapy in leprosy.
Girdhar BK
Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
[No Abstract] [Full Text] [Related]
9. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
10. The chemotherapy of leprosy. Part 2.
Ellard GA
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
[No Abstract] [Full Text] [Related]
11. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
Shetty VP; Wakade A; Antia NH
Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
[No Abstract] [Full Text] [Related]
12. [New trends in the treatment of leprosy].
Koźmińska-Kubarska A
Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636
[No Abstract] [Full Text] [Related]
13. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
14. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
Ghorpade A
Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
[No Abstract] [Full Text] [Related]
15. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
16. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
17. Leprosy in HIV infection: a study of three cases.
Rath N; Kar HK
Indian J Lepr; 2003; 75(4):355-9. PubMed ID: 15242274
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
19. New developments in the chemotherapy of leprosy.
Freerksen E
Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
[No Abstract] [Full Text] [Related]
20. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
[Next] [New Search]